Safety, pharmacokinetics and pharmacodynamics of TAK‐418, a novel inhibitor of the epigenetic modulator lysine‐specific demethylase 1A - Concepedia

Concepedia

Publication | Open Access

Safety, pharmacokinetics and pharmacodynamics of TAK‐418, a novel inhibitor of the epigenetic modulator lysine‐specific demethylase 1A

DOI Full Paper Access

22

Citations

8

References

2021

Year

Wei Yin, Dimitrios Arkilo, Polyna Khudyakov, Jim Hazel, Saurabh Gupta, Maria S. Quinton, Jie Lin, Deborah Hartman, Martin M. Bednar, Laura Rosen,

British Journal of Clinical Pharmacology

Abstract

The brain-penetrant LSD1 inhibitor TAK-418 was well tolerated, with pharmacokinetic and pharmacodynamic effects that support further investigation.

References

	Year	Citations

Page 1